Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed EV 3.6 S - 11 mm: medical device reports filed with FDA

3,667 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

3,667
device reports naming the brand
0% of all MAUDE reports · about 518 a year
531
reports, 12 months to August 2026
493 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

3,667 medical device reports received by FDA name the brand "OsseoSpeed EV 3.6 S - 11 mm" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

531 reports arrived in the 12 months to August 2026, close to the 493 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (49.9%), failure to osseointegrate (25.7%) and loss of osseointegration (21.4%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04590Sep 2021: 29Oct 2021: 29Nov 2021: 29Dec 2021: 452022Jan 2022: 42Feb 2022: 24Mar 2022: 29Apr 2022: 23May 2022: 33Jun 2022: 39Jul 2022: 14Aug 2022: 23Sep 2022: 24Oct 2022: 22Nov 2022: 35Dec 2022: 242023Jan 2023: 44Feb 2023: 36Mar 2023: 15Apr 2023: 21May 2023: 28Jun 2023: 22Jul 2023: 12Aug 2023: 15Sep 2023: 17Oct 2023: 28Nov 2023: 24Dec 2023: 262024Jan 2024: 39Feb 2024: 27Mar 2024: 31Apr 2024: 27May 2024: 27Jun 2024: 36Jul 2024: 31Aug 2024: 46Sep 2024: 41Oct 2024: 33Nov 2024: 15Dec 2024: 262025Jan 2025: 49Feb 2025: 29Mar 2025: 61Apr 2025: 41May 2025: 23Jun 2025: 33Jul 2025: 68Aug 2025: 74Sep 2025: 58Oct 2025: 19Nov 2025: 39Dec 2025: 372026Jan 2026: 90Feb 2026: 32Mar 2026: 38Apr 2026: 64May 2026: 34Jun 2026: 34Jul 2026: 65Aug 2026: 21

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

07901,5792019: 18020192021: 1,57920212022: 33220222023: 28820232024: 37920242025: 53120252026: 3782026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,667
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%3,667
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem1,83049.9%7.7%
Failure to osseointegrate94325.7%62.8%
Loss of osseointegration78321.4%22.4%
Fracturea broken bone1433.9%1.6%
Loosening of implant not related to bone-ingrowth170.5%0.1%
Crackthe device cracked70.2%0%
Insufficient device problem information20.1%0.2%
Device dislodged or dislocated10%0%
Off-label use10%0%
Patient-device incompatibilitythe device did not suit the patient10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant3,66599.9%
Inflammationinflammation40010.9%
Pocket erosion1604.4%
Osteolysis1534.2%
Hypersensitivity/allergic reaction40.1%
Painpain, site not specified30.1%
Purulent discharge20.1%
Swelling/ edema20.1%
Abscessa collection of pus10%
Discomfortdiscomfort10%
Fistula10%
Impaired healingslow healing10%
Inadequate osseointegration10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed EV 3.6 S - 11 mmProduct code DZEAll MAUDE reports
Reports3,6673,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed EV 3.6 S - 11 mm reports

How many FDA reports name OsseoSpeed EV 3.6 S - 11 mm?

3,667 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 531 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (49.9%), failure to osseointegrate (25.7%), loss of osseointegration (21.4%), fracture (3.9%) and loosening of implant not related to bone-ingrowth (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed EV 3.6 S - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.